Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Denosumab

Brand: Prolia┬«
NICE TA: 
Indication: Prevention of osteoporotic fractures in men
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Recommendation

LMMG recommendation: Amber1
Click here to find the definitions for the colour classifications

Reason for decision:  Shared care required

Supporting documents:

Denosumab Position Statement (Version 1.0) (291.3 KiB)

Denosumab Shared Care Guideline Version 4.1 (290.1 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber

Amber1

Amber1

Amber1

Amber1

Amber1